<DOC>
	<DOC>NCT02244619</DOC>
	<brief_summary>The purpose of the study is to evaluate post-op pain requirements in patients undergoing hip or knee replacement surgery who perioperatively receive either Oral acetaminophen or IV acetaminophen</brief_summary>
	<brief_title>PO vs. IV Acetaminophen Given Perioperatively for 24 hr Post-op Pain Control Following Total Hip or Knee Replacement</brief_title>
	<detailed_description>Subjects will be randomized to receive perioperative dosing of either: 1. Oral acetaminophen (Tylenol) 1000mg with IV Placebo (100ml Normal Saline), OR, 2. IV acetaminophen (Ofirmev) 1000mg/100ml with Oral Placebo (oral capsules). Subject pain levels and post-operative opioid use will be tracked for up to 24 hours after surgery.</detailed_description>
	<mesh_term>Pain, Postoperative</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>18 years of age and older Able to provide written consent Able to read and write in English Weighing over 50 kg Will undergo total hip or total knee joint replacement Nonverbal patients Unable to use numeric pain scale Allergic to the test article Documented hepatic impairment or failure Current illicit drug use Requires traumatic or emergent surgery Pregnant women Women who are breastfeeding Prisoners Cognitively impaired requiring Legally Authorized Representative (LAR) or Power of Attorney (POA) Unable to swallow oral capsules</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Hip replacement</keyword>
	<keyword>Knee replacement</keyword>
	<keyword>randomized trial</keyword>
	<keyword>acetaminophen</keyword>
	<keyword>post-op pain management</keyword>
</DOC>